A citation-based method for searching scientific literature

Keiji Suzuki, Vladimir Saenko, Shunichi Yamashita, Norisato Mitsutake. Cancers (Basel) 2019
Times Cited: 10







List of co-cited articles
59 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



RET Gene Fusions in Malignancies of the Thyroid and Other Tissues.
Massimo Santoro, Marialuisa Moccia, Giorgia Federico, Francesca Carlomagno. Genes (Basel) 2020
39
40

Precision Targeted Therapy with BLU-667 for RET-Driven Cancers.
Vivek Subbiah, Justin F Gainor, Rami Rahal, Jason D Brubaker, Joseph L Kim, Michelle Maynard, Wei Hu, Qiongfang Cao, Michael P Sheets, Douglas Wilson,[...]. Cancer Discov 2018
215
40

American Thyroid Association guidelines for management of patients with anaplastic thyroid cancer.
Robert C Smallridge, Kenneth B Ain, Sylvia L Asa, Keith C Bible, James D Brierley, Kenneth D Burman, Electron Kebebew, Nancy Y Lee, Yuri E Nikiforov, M Sara Rosenthal,[...]. Thyroid 2012
443
30

Lenvatinib versus placebo in radioiodine-refractory thyroid cancer.
Martin Schlumberger, Makoto Tahara, Lori J Wirth, Bruce Robinson, Marcia S Brose, Rossella Elisei, Mouhammed Amir Habra, Kate Newbold, Manisha H Shah, Ana O Hoff,[...]. N Engl J Med 2015
30

The prevalence and prognostic value of BRAF mutation in thyroid cancer.
Electron Kebebew, Julie Weng, Juergen Bauer, Gustavo Ranvier, Orlo H Clark, Quan-Yang Duh, Daniel Shibru, Boris Bastian, Ann Griffin. Ann Surg 2007
336
30

Safety and antitumor activity of the anti-PD-1 antibody pembrolizumab in patients with advanced, PD-L1-positive papillary or follicular thyroid cancer.
Janice M Mehnert, Andrea Varga, Marcia S Brose, Rahul R Aggarwal, Chia-Chi Lin, Amy Prawira, Filippo de Braud, Kenji Tamura, Toshihiko Doi, Sarina A Piha-Paul,[...]. BMC Cancer 2019
85
30

NTRK gene fusions as novel targets of cancer therapy across multiple tumour types.
Alessio Amatu, Andrea Sartore-Bianchi, Salvatore Siena. ESMO Open 2016
308
30

Molecular Alterations in Thyroid Cancer: From Bench to Clinical Practice.
Elena Tirrò, Federica Martorana, Chiara Romano, Silvia Rita Vitale, Gianmarco Motta, Sandra Di Gregorio, Michele Massimino, Maria Stella Pennisi, Stefania Stella, Adriana Puma,[...]. Genes (Basel) 2019
52
30

Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial.
Marcia S Brose, Christopher M Nutting, Barbara Jarzab, Rossella Elisei, Salvatore Siena, Lars Bastholt, Christelle de la Fouchardiere, Furio Pacini, Ralf Paschke, Young Kee Shong,[...]. Lancet 2014
877
30

Evolving Understanding of the Epidemiology of Thyroid Cancer.
Carolyn Dacey Seib, Julie Ann Sosa. Endocrinol Metab Clin North Am 2019
143
20

Pax-8-PPAR-γ fusion protein in thyroid carcinoma.
Priyadarshini Raman, Ronald J Koenig. Nat Rev Endocrinol 2014
74
20

PD-1 Ligand Expression in Epithelial Thyroid Cancers: Potential Clinical Implications.
Salvatore Ulisse, Chiara Tuccilli, Salvatore Sorrenti, Alessandro Antonelli, Poupak Fallahi, Eleonora D'Armiento, Antonio Catania, Francesco Tartaglia, Maria Ida Amabile, Laura Giacomelli,[...]. Int J Mol Sci 2019
26
20

Efficacy of Larotrectinib in TRK Fusion-Positive Cancers in Adults and Children.
Alexander Drilon, Theodore W Laetsch, Shivaani Kummar, Steven G DuBois, Ulrik N Lassen, George D Demetri, Michael Nathenson, Robert C Doebele, Anna F Farago, Alberto S Pappo,[...]. N Engl J Med 2018
20

Vemurafenib in Multiple Nonmelanoma Cancers with BRAF V600 Mutations.
David M Hyman, Igor Puzanov, Vivek Subbiah, Jason E Faris, Ian Chau, Jean-Yves Blay, Jürgen Wolf, Noopur S Raje, Eli L Diamond, Antoine Hollebecque,[...]. N Engl J Med 2015
20

Targeted Therapy in Advanced Thyroid Cancer to Resensitize Tumors to Radioactive Iodine.
Tania Jaber, Steven G Waguespack, Maria E Cabanillas, Mohamed Elbanan, Thinh Vu, Ramona Dadu, Steven I Sherman, Moran Amit, Elmer B Santos, Mark Zafereo,[...]. J Clin Endocrinol Metab 2018
50
20

Hypertension induced by the tyrosine kinase inhibitor sunitinib is associated with increased circulating endothelin-1 levels.
Mariëtte H W Kappers, Joep H M van Esch, Wim Sluiter, Stefan Sleijfer, A H Jan Danser, Anton H van den Meiracker. Hypertension 2010
190
20

PAX8/PPARγ rearrangement in thyroid nodules predicts follicular-pattern carcinomas, in particular the encapsulated follicular variant of papillary carcinoma.
Michaele J Armstrong, Huaitao Yang, Linwah Yip, N Paul Ohori, Kelly L McCoy, Michael T Stang, Steven P Hodak, Marina N Nikiforova, Sally E Carty, Yuri E Nikiforov. Thyroid 2014
47
20

RAS mutations in thyroid cancer.
Gina M Howell, Steven P Hodak, Linwah Yip. Oncologist 2013
111
20


New Insights in Thyroid Cancer and p53 Family Proteins.
Livia Manzella, Stefania Stella, Maria Stella Pennisi, Elena Tirrò, Michele Massimino, Chiara Romano, Adriana Puma, Martina Tavarelli, Paolo Vigneri. Int J Mol Sci 2017
44
20

Lenvatinib for Anaplastic Thyroid Cancer.
Makoto Tahara, Naomi Kiyota, Tomoko Yamazaki, Naoko Chayahara, Kenji Nakano, Lina Inagaki, Kazuhisa Toda, Tomohiro Enokida, Hironobu Minami, Yoshinori Imamura,[...]. Front Oncol 2017
94
20

Vemurafenib in patients with BRAF(V600E)-positive metastatic or unresectable papillary thyroid cancer refractory to radioactive iodine: a non-randomised, multicentre, open-label, phase 2 trial.
Marcia S Brose, Maria E Cabanillas, Ezra E W Cohen, Lori J Wirth, Todd Riehl, Huibin Yue, Steven I Sherman, Eric J Sherman. Lancet Oncol 2016
186
20


Selective RET kinase inhibition for patients with RET-altered cancers.
V Subbiah, V Velcheti, B B Tuch, K Ebata, N L Busaidy, M E Cabanillas, L J Wirth, S Stock, S Smith, V Lauriault,[...]. Ann Oncol 2018
211
20

Genetic Landscape of Somatic Mutations in a Large Cohort of Sporadic Medullary Thyroid Carcinomas Studied by Next-Generation Targeted Sequencing.
Raffaele Ciampi, Cristina Romei, Teresa Ramone, Alessandro Prete, Alessia Tacito, Virginia Cappagli, Valeria Bottici, David Viola, Liborio Torregrossa, Clara Ugolini,[...]. iScience 2019
58
20

Mutational profile of advanced primary and metastatic radioactive iodine-refractory thyroid cancers reveals distinct pathogenetic roles for BRAF, PIK3CA, and AKT1.
Julio C Ricarte-Filho, Mabel Ryder, Dhananjay A Chitale, Michael Rivera, Adriana Heguy, Marc Ladanyi, Manickam Janakiraman, David Solit, Jeffrey A Knauf, R Michael Tuttle,[...]. Cancer Res 2009
372
20

RET proto-oncogene: a review and update of genotype-phenotype correlations in hereditary medullary thyroid cancer and associated endocrine tumors.
Maria A Kouvaraki, Suzanne E Shapiro, Nancy D Perrier, Gilbert J Cote, Robert F Gagel, Ana O Hoff, Steven I Sherman, Jeffrey E Lee, Douglas B Evans. Thyroid 2005
185
20

Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma.
Samuel A Wells, Sylvia L Asa, Henning Dralle, Rossella Elisei, Douglas B Evans, Robert F Gagel, Nancy Lee, Andreas Machens, Jeffrey F Moley, Furio Pacini,[...]. Thyroid 2015
988
20

BRAF mutation in thyroid cancer.
M Xing. Endocr Relat Cancer 2005
951
20

Radioiodine-Refractory Thyroid Cancer: Molecular Basis of Redifferentiation Therapies, Management, and Novel Therapies.
Mohamed Aashiq, Deborah A Silverman, Shorook Na'ara, Hideaki Takahashi, Moran Amit. Cancers (Basel) 2019
46
20

Cabozantinib in progressive medullary thyroid cancer.
Rossella Elisei, Martin J Schlumberger, Stefan P Müller, Patrick Schöffski, Marcia S Brose, Manisha H Shah, Lisa Licitra, Barbara Jarzab, Viktor Medvedev, Michael C Kreissl,[...]. J Clin Oncol 2013
685
20

Dabrafenib and Trametinib Treatment in Patients With Locally Advanced or Metastatic BRAF V600-Mutant Anaplastic Thyroid Cancer.
Vivek Subbiah, Robert J Kreitman, Zev A Wainberg, Jae Yong Cho, Jan H M Schellens, Jean Charles Soria, Patrick Y Wen, Christoph Zielinski, Maria E Cabanillas, Gladys Urbanowitz,[...]. J Clin Oncol 2018
385
20


Role of the wnt pathway in thyroid cancer.
Ana Sastre-Perona, Pilar Santisteban. Front Endocrinol (Lausanne) 2012
80
20

Evidence of a low prevalence of RAS mutations in a large medullary thyroid cancer series.
Raffaele Ciampi, Caterina Mian, Laura Fugazzola, Barbara Cosci, Cristina Romei, Susi Barollo, Valentina Cirello, Valeria Bottici, Giulia Marconcini, Pelizzo Maria Rosa,[...]. Thyroid 2013
109
20

Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: integrated analysis of three phase 1-2 trials.
Robert C Doebele, Alexander Drilon, Luis Paz-Ares, Salvatore Siena, Alice T Shaw, Anna F Farago, Collin M Blakely, Takashi Seto, Byung Chul Cho, Diego Tosi,[...]. Lancet Oncol 2020
535
20

Lenvatinib for thyroid cancer treatment: discovery, pre-clinical development and clinical application.
Rosa Maria Paragliola, Andrea Corsello, Valeria Del Gatto, Giampaolo Papi, Alfredo Pontecorvi, Salvatore Maria Corsello. Expert Opin Drug Discov 2020
6
33

Highly prevalent genetic alterations in receptor tyrosine kinases and phosphatidylinositol 3-kinase/akt and mitogen-activated protein kinase pathways in anaplastic and follicular thyroid cancers.
Zhi Liu, Peng Hou, Meiju Ji, Haixia Guan, Kimberly Studeman, Kirk Jensen, Vasily Vasko, Adel K El-Naggar, Mingzhao Xing. J Clin Endocrinol Metab 2008
289
20

Dysregulation of the phosphatidylinositol 3-kinase pathway in thyroid neoplasia.
John E Paes, Matthew D Ringel. Endocrinol Metab Clin North Am 2008
77
20

Gene Fusions in Thyroid Cancer.
Valentina D Yakushina, Larisa V Lerner, Alexander V Lavrov. Thyroid 2018
56
20

Molecular pathology of hereditary and sporadic medullary thyroid carcinomas.
Rebecca D Chernock, Ian S Hagemann. Am J Clin Pathol 2015
18
20

Vandetanib in patients with locally advanced or metastatic medullary thyroid cancer: a randomized, double-blind phase III trial.
Samuel A Wells, Bruce G Robinson, Robert F Gagel, Henning Dralle, James A Fagin, Massimo Santoro, Eric Baudin, Rossella Elisei, Barbara Jarzab, James R Vasselli,[...]. J Clin Oncol 2012
877
20

TERT promoter mutations in thyroid cancer.
Rengyun Liu, Mingzhao Xing. Endocr Relat Cancer 2016
206
20

Frequency and Significance of Ras, Tert Promoter, and Braf Mutations in Cytologically Indeterminate Thyroid Nodules: A Monocentric Case Series at a Tertiary-Level Endocrinology Unit.
Simona Censi, Elisabetta Cavedon, Loris Bertazza, Francesca Galuppini, Sara Watutantrige-Fernando, Paola De Lazzari, Davide Nacamulli, Gianmaria Pennelli, Ambrogio Fassina, Maurizio Iacobone,[...]. Front Endocrinol (Lausanne) 2017
24
20

Clinicopathologic and Prognostic Significance of Programmed Cell Death Ligand 1 Expression in Patients with Non-Medullary Thyroid Cancer: A Systematic Review and Meta-Analysis.
Marra Aghajani, Susannah Graham, Charles McCafferty, Christina Abdel Shaheed, Tara Roberts, Paul DeSouza, Tao Yang, Navin Niles. Thyroid 2018
27
20

Integrated Genomic Analysis of Hürthle Cell Cancer Reveals Oncogenic Drivers, Recurrent Mitochondrial Mutations, and Unique Chromosomal Landscapes.
Ian Ganly, Vladimir Makarov, Shyamprasad Deraje, YiYu Dong, Ed Reznik, Venkatraman Seshan, Gouri Nanjangud, Stephanie Eng, Promita Bose, Fengshen Kuo,[...]. Cancer Cell 2018
121
20

Mechanisms of receptor tyrosine kinase activation in cancer.
Zhenfang Du, Christine M Lovly. Mol Cancer 2018
298
20

Rearrangements of NTRK1 gene in papillary thyroid carcinoma.
A Greco, C Miranda, M A Pierotti. Mol Cell Endocrinol 2010
126
20

Selumetinib-enhanced radioiodine uptake in advanced thyroid cancer.
Alan L Ho, Ravinder K Grewal, Rebecca Leboeuf, Eric J Sherman, David G Pfister, Desiree Deandreis, Keith S Pentlow, Pat B Zanzonico, Sofia Haque, Somali Gavane,[...]. N Engl J Med 2013
483
20


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.